Venable

Venable LLP: Patent Litigation Summary

Venable LLP is a full-service, Am Law 100 firm with a significant national presence and a robust intellectual property litigation practice. Headquartered in Washington, D.C., the firm has more than 850 professionals across offices in key markets including New York, California, Delaware, Illinois, and Florida. In 2026, The American Lawyer ranked Venable #68 in its Am Law 100 survey based on gross revenue. The firm provides a wide range of legal services, with its IP group handling complex patent, trademark, and copyright litigation for a diverse client base.

The firm's patent litigation practice is characterized by its work in both the life sciences and high-technology sectors. In the life sciences, Venable has a long-standing practice representing branded pharmaceutical companies in Hatch-Waxman litigation, as well as handling disputes for biotech and medical device manufacturers. The technology practice litigates cases across a wide array of fields, including automotive, software, telecommunications, semiconductors, and medical devices. The firm represents clients in federal district courts nationwide, at the U.S. International Trade Commission (ITC), and before the U.S. Court of Appeals for the Federal Circuit.

Venable represents both patent holders and accused infringers. While the provided data shows a recent plaintiff-side appearance in Promotion In Motion Inc v. New Cibo Vita LLC et al., the firm's broader practice is balanced. The firm states it is "equally adept at both fighting for rights holders and defending accused infringers." This is demonstrated by its successful representation of patent owner Vectura in a case against GlaxoSmithKline that resulted in an $89.7 million jury verdict, and its complete defense victory for a leading smart thermostat manufacturer in three separate ITC investigations. The firm has also secured significant wins for patent holders in the pharmaceutical industry, such as obtaining summary judgment for Novartis concerning its Entresto® heart failure product.

The firm maintains an active practice before the Patent Trial and Appeal Board (PTAB), describing itself as one of the leading firms in this area with experience in hundreds of post-grant proceedings, including inter partes reviews (IPRs), reexaminations, and interferences. Key partners in the IP litigation practice include Megan S. Woodworth, who co-chairs the IP Litigation – Technology Group and has experience before the ITC, PTAB, and Federal Circuit. William D. Coston is a veteran litigator with a focus on IP and antitrust matters, who has argued and won a landmark trade dress case before the U.S. Supreme Court. Daniel E. Venglarik appeared as lead counsel for the firm in the tracked Promotion In Motion case; he is not currently listed as an attorney at the firm. Dominick Conde is noted as a co-chair of the IP Division with a focus on pharmaceutical and ANDA litigation.